Olopatadine Hydrochloride
"Olopatadine Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antihistamine with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.
| Descriptor ID |
D000069605
|
| MeSH Number(s) |
D03.633.300.382.696
|
| Concept/Terms |
Olopatadine- Olopatadine
- 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid
|
Below are MeSH descriptors whose meaning is more general than "Olopatadine Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Olopatadine Hydrochloride".
This graph shows the total number of publications written about "Olopatadine Hydrochloride" by people in this website by year, and whether "Olopatadine Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Olopatadine Hydrochloride" by people in Profiles.
-
Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opin Pharmacother. 2017 Aug; 18(11):1137-1143.
-
Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
-
Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis. Expert Opin Drug Metab Toxicol. 2011 Dec; 7(12):1593-9.
-
Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis? Allergy Asthma Proc. 2009 Mar-Apr; 30(2):212-3; author reply 213-4.
-
Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. Adv Ther. 2003 Mar-Apr; 20(2):79-91.